2m 2m 2m 2m 2m 2m 2m
Nuo Therapeutics (AURX)
OTC
$1.30$0.00 (0.00%)
Price as of Oct 22, 2026- $63.0MMarket Cap
- -45.83%1-Year Change
- BiotechnologyIndustry
Nuo Therapeutics (AURX)
$1.30$0.00 (0.00%)
AURX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.30 | ||
Change | $0.00 (0.00%) | ||
Open | $1.30 | ||
High | $1.30 | ||
Low | $1.30 | ||
Previous Close | $1.30 | ||
Volume | 100 | ||
30-Day Average Volume | 9,098 | ||
1-Week Change | 0.00% | ||
1-Month Change | 0.00% | ||
1-Year Change | -45.83% | ||
3-Year Change | 144.71% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 48.4M | ||
Total Assets | $2.6M | ||
Market Cap | $63.0M | ||
Enterprise Value | $64.0M | ||
Period: QTR TTM FY | |||
Revenue | $1.7M | ||
Net Income | -$277,601.00 | ||
Free Cash Flow | -$489,502.00 | ||
EBIT | -$163,535.00 | ||
EBITDA | -$137,337.00 | ||
Net Working Capital | $439,434.00 | ||
EPS | -$0.01 | ||
Enterprise Value/EBITDA | -466 | ||
Enterprise Value/Revenue | 38 | ||
P/B | -41 | ||
P/E | -130 | ||
PEG | N/A | ||
Price/Free Cash Flow | -129 | ||
Price/Operating Cash Flow | -266 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue